NLRP3 and depressive symptom measurement: NLRP3 function can also be modulated through the inhibition of CYP17A1 and CYP19A1 via clotrimazole (30 mg/kg/day) [144], which produces an anti-inflammatory response and reduces depression-like behaviors.